FDA Inspection 1277615 — Carroll-Baccari Inc

Carroll-Baccari Inc — FEI 3017189082

The FDA completed an inspection of Carroll-Baccari Inc on Aug 5, 2025 in Flat Rock, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 13 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 5, 2025
Fiscal Year
2025
Product Type
Devices
Project Area
Compliance: Devices
Location
Flat Rock, NC (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1472221 CFR 820.40Procedures not adequately established or maintained
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
310821 CFR 820.70(e)Contamination control, Lack of or inadequate procedures
311721 CFR 820.70(i)Software validation for automated processes
312821 CFR 820.90(a)Nonconforming product control
313021 CFR 820.100(a)Lack of or inadequate procedures
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
48621 CFR 820.50(a)Evaluation of suppliers, contractors, etc., requirements
50221 CFR 820.60Identification procedures, Lack of or inadequate procedures
63021 CFR 803.17Lack of Written MDR Procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.